Wire report

Hundreds of children in England prescribed weight-loss jabs, figures show

Exclusive: investigation finds prescriptions for children under 12, as experts stress need for specialist supervision and long-term monitoring Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal. GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar levels, but have since become a popular slimming aid, with products such as Wegovy and Mounjaro becoming household names. Continue reading...

Image from linked report: Hundreds of children in England prescribed weight-loss jabs, figures show
Image from the linked report: Hundreds of children in England prescribed weight-loss jabs, figures show.Credit: The Guardian Thumbnail shown with attribution and outbound source link; VINI does not claim ownership or republish the original article body. Image source Image shown with attribution and an outbound source link; VINI does not claim ownership or republish the original article body.
Reading time1 min

coverage / Wire report

Reader toolsFollow the reporting.

Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.

FollowGet story updatesBriefs and topic returnsContextOpen background1 public sourceContributeSend recordsDocuments, dates, photosSupportFund reportingReader-backed workShareCopy story URLvininews.com
Why it mattersScience

Exclusive: investigation finds prescriptions for children under 12, as experts stress need for specialist supervision and long-term monitoring Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal. GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar levels, but have since become a popular slimming aid, with products such as Wegovy and Mounjaro becoming household names. Continue reading...

What to know1 source

Check the original link, updates, and responses when a detail is contested.

Keep readingmedical

Open topic or search related wording such as records, sources, agencies, dates, and locations.

What happened

According to The Guardian’s source item, Hundreds of children in England prescribed weight-loss jabs, figures show, Exclusive: investigation finds prescriptions for children under 12, as experts stress need for specialist supervision and long-term monitoring Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal. GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar levels, but have since become a popular slimming aid, with products such as Wegovy and Mounjaro becoming household names. Continue reading…

Context

The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-11-14T08:00:39+00:00.

What to watch

Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.

Source

Primary source: Hundreds of children in England prescribed weight-loss jabs, figures show via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.

Keep following

This file can keep developing

vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.

SubscribeGet the next updateSend recordsShare documents or leadsRespondRequest comment or replyDonateSupport reporting costs

Support and subscriptions never buy coverage, placement, suppression, or corrections.

This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.

Source links

Reader comments

Moderated discussion

Account access

Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.

Loading comments.

No approved comments yet.

Substantive, civil comments can be submitted by approved account holders.